Blood Test for Alzheimer’s Cleared by FDA
An FDA-cleared blood test that measures key Alzheimer’s disease biomarkers is a less invasive, more accurate method to diagnose the condition.
Category: Dementias & Alzheimer’s
Dementias & Alzheimer’s
Latest
Dementias & Alzheimer’s
Latest
IL-12 Is the Messenger Fueling Alzheimer’s
Microglia can transition from protective to harmful with age, producing inflammatory messengers like IL-12, which accelerates Alzheimer’s.
Dementias & Alzheimer’s
Latest
Neurocode Study Compares Alzheimer’s Assays
Neurocode USA Inc. published a study showing that its ALZpath pTau217 assay outperforms the Fujirebio assay in detecting Alzheimer's disease.
Structure of Huntington’s Disease Protein Clumps Identified
Researchers have visualized the atomic-level structure of protein clumps linked to Huntington’s disease, paving the way for diagnostic tools.
Read More
Alpha-Synuclein: Adding Precision to Neurodegenerative Testing
This episode of Clinical Lab Chat covers the how and why of making precise clinical diagnosis of neurodegenerative diseases.
Read More
Universities Collaborate on Validating Blood Test for Early Alzheimer’s Detection
Two universities are conducting a validation study on a blood test designed to detect early neurodegeneration in Alzheimer’s disease.
Read More
How a Skin Biopsy Can Evaluate Synucleinopathies
A new study demonstrates the clinical utility of a skin biopsy diagnostic tool in improving care for those with neurodegenerative diseases.
Read More
New Blood Test Biomarker Could Detect Dementia Risk Earlier and More Cost-Effectively
Researchers identified a promising blood biomarker for detecting vascular contributions to cognitive impairment and dementia.
Read More
Preparing Your Lab for Blood-Based Alzheimer’s Disease Testing
Blood-based diagnostics for Alzheimer’s disease and other neurological conditions could be here sooner than you think.
Read More
Researchers Explore Reliable Ways to Diagnose Alzheimer’s
Researchers explored how combining CSF analysis and amyloid PET imaging can improve the accuracy and efficiency of Alzheimer’s diagnosis.
Read More
VeraBIND Tau Assay for Alzheimer’s Detection Gets Positive Study Feedback
Study results were revealed for the VeraBIND Tau assay diagnostic test designed to detect active Alzheimer’s disease pathology.
Read More
Finger-Prick Blood Test Could Revolutionize Alzheimer’s Detection
A new capillary blood test offers a simple, mail-in method to detect Alzheimer’s biomarkers, paving the way for accessible global testing.
Read More
Blood Test Detects Parkinson’s Disease Through Alpha Synuclein Biomarkers
Sunbird Bio demonstrated that its blood-based alpha synuclein biomarkers can accurately detect Parkinson’s disease.
Read More
Veravas and Phanes Biotech Partner to Develop Alzheimer’s Tau Pathology Test
Veravas and Phanes Biotech are collaborating to create a blood test using VeraBIND technology to detect Alzheimer’s tau pathology early.
Read More
Roche Presents New Alzheimer’s Disease Diagnostic Data
Roche announced the Elecsys Amyloid Plasma Panel shows promising results in accurately ruling out amyloid pathology in Alzheimer’s disease.
Read More
Olfactory Loss Linked to 100-Plus Diseases
Researchers have found a significant link between olfactory loss in 139 medical conditions, highlighting the role of smell plays.
Read More
New Multi-Marker Blood Test Enhances Alzheimer’s Detection
Lucent Diagnostics launched a blood test using five Alzheimer’s-related biomarkers to improve detection accuracy and reduce invasive testing.
Read More
BrainScope Completes Proof-of-Concept for Early Alzheimer’s Prediction Biomarker
BrainScope completed the proof-of-concept phase for a novel EEG-based biomarker capable of predicting the onset of Alzheimer’s disease.
Read More